For use in screening for environmental mutagens and carcinogens, a highly fluorescent derivative of guanosine, 2'-deoxy-2'-(2",3"-dihydro-2",4"-diphenyl-2"-hydroxy-3"-oxo-l"-pyrrolyl)guanosine (FG), was synthesized. When incubated with FG in aqueous solution, mutagens form adducts that can be analyzed with an HPLC-fluorescence detector-system. By this method, mutagens such as glyoxal, methylglyoxal, 2-(2-furyl)-3-(5-nitrofuryl)acrylamide and 4-nitroquinoline-N-oxide, used as model compounds, were detected rapidly with high sensitivity.
INTRODUCTION
Many mutagens and carcinogens react with base residues in DNA, particularly guanine residues, and so it is possible to detect them as adducts after treatment with a guanosine derivative. For this purpose, we synthesized a new fluorescent derivative of guanosine, 2'-deoxy-2'-(2",3"-dihydro-2",4"-diphenyl-2"-hydroxy-3"-oxo-l"-pyrrolyl)guanosine (FG) in which a fluorescent group is attached to the sugar moiety. After treatment of samples with this reagent with or without S9 mix, adducts could be detected with high sensitivity by high performance liquid chromatography (HPLC) in an apparatus connected with a fluorescence detector. Furthermore, all procedures, including preincubation with or without S9 mix could be complete within 1 hr.
For structural characterization of mutagens and carcinogens, we found that adducts with isopropylideneguanosine (IPG) were more suitable than those with FG. This method with IPG was applied to a sample of heated glucose, which has been reported to be mutagenic to Salmonella strain TAIOO.T he sample was treated with IPG, and the adducts were isolated by HPLC and characterized by spectral measurements.
This communication shows that certain mutagens or carcinogens can be rapidly detected with high sensitivity with or without S9 mix by the former method. The identification of adducts formed by the reaction of IPG with heated glucose is given as an example of application of the latter method.
MATERIALS AND METHODS

Materials.
Glyoxal (Tokyo Kasei), methylglyoxal (Aldrich), benzo Isopropylideneguanosine and 8-bromoguanosine were purchased from Sigma.
2-Methoxy-2,4-diphenyl-3(2H)-furanone(MDPF) was obtained from Tokyo Kasei.
2'-Amino-2'-deoxyguanosine was a gift from Dr. F. Tomita (Kyowa Hakko Kogyo). Diaion HP-20 was purchased from Mitsubishi Chemical Industries.
Preparation of 2'-deoxy-2'-(2",3"-dihydro-2",4"-diphenyl-2"-hydroxy-3"-oxol"-pyrrolyl)guanosine (FG) A solution of 2'-deoxy-2'-aminoguanosine (40 mg: 0.14 mmol) and triethylamine (14 mg: 0.14 mmol) in 5 ml of water/MeOH (1:1, v/v) was mixed with a solution of MDPF (40 rag: 0.15 mmol) in 2 ml of MeOH at 50°C. The mixture was kept for 10 min at 50°C and then cooled to room temperature.
It was then diluted with 50 ml of water and passed through a column of Diaion HP-20 (1.5 cm x 20 cm). The column was washed with 200 ml of water and then material was eluted with a linear gradient obtained by placing 500 ml of water in the mixing chamber and 500ml of 50% aqueous MeOH in the reservoir. Fluorescent fractions were collected and evaporated to dryness to afford an amorphous solid, consisting of two diastereomeric components (major lsomer: minor isomer=15:l, based on H-NMR spectra Reaction of mutagens with FG Solutions ^100 PI) of the direct acting mutagens glyoxal and methyl glyoxal (50 yg/100 VI DMSO) were each mixed with 100 yl of solution of FG (50 yg/100 yl H 2 0) and 500 yl of sodium phosphate buffer (100 mM, pH 6.8)
in a test tube (1x8 cm). The solutions (total 0.7 ml) were shaken at 37°C
for 20 In experiments with 4NQ0, AF-2, AAF, BP and IQ, 100 yl of solutions of these mutagens (50 yg/100 yl DMSO) were mixed with 100 yl of solution of FG (50 yg/100 yl HO) and 500 yl of S9 mix (pH 7.4). S9 mix consisted of 30 yl of S9, 2 ymol NADPH and 2.5 ymol glucose-6-phosphate, 4 ymol MgCl , 16.5 y mol KC1 and 50 ymol sodium phosphate buffer (pH 7.4) in a total of 0.5 ml.
Reaction of isopropylideneguanosine with heated glucose and isolation of adducts by HPLC Glucose (10 g) in a 500 ml Erlenmeyer flask was heated on an oil bath at 200°C. Heating was continued for 20 min after all the glucose had melted. The heated glucose was cooled to room temperature and dissolved in 100 ml of a solution of 100 mg of isopropylideneguanosine in 25 mM sodium phosphate buffer (pH 6.8). The brown solution obtained was kept in an incubator at 37°C for 15 hrs.
The reaction mixture (100 ml) was extracted with ethyl acetate (100 ml each x 5) and the extract was evaporated to dryness. The residue was suspended in 15% MeOH solution (5 ml) and centrifuged. The permethyl derivative of synthetic FG was prepared using methylsulfinyl carbanion and methyl iodide as described previously.
Nuclear magnetic resonance spectroscopy First 2 A units of adduct-2 was lyophilized from 99.5% CD 0D and dissolved in 99.95* CD 0D (Merk) in a glove bag filled with nitrogen gas.
The proton NMR spectrum of adduct-2 in CD 0D was recorded in a Bruker CXP-300 spectrometer at 23°C. Chemical shifts were measured relative to the residual CHD 0D signal (3.40 ppm).
Mutation assay S. typhimurium mutant TA100 was used for mutation assay. Assays were performed by the preincubation method without S9 mix, using two plates for each concentration of sample. Specific activity was calculated from the data within the linear dose-response range.
RESULTS AND DISCUSSION
2-Methoxy-2,4-diphenyl-3(2H)-furanone (MDPF, structure 2) has been used 7 f or fluorescent labeling of amino groups in protein.
We chose it for fluorescent labeling of 2'-amino-2 1 -deoxyguanosine (structure 1) because it reacts selectively with the 2'-amino group in the sugar moiety, and does not react with the 2-amino group of the guanine base. As MDPF is not itself fluorescent, and on reaction it gives a single fluorescent product, this product was easily separated by column chromatography with fluorescence monitoring. The fluorescent product (FG, structure 3) was found to be extremely stable over a wide range of pH values. It could be extracted from the aqueous reaction mixture with an organic solvent such as ethyl acetate. 8 9
When the typical direct acting mutagens glyoxal and methylglyoxal were incubated with a solution of FG and then analyzed by HPLC in an apparatus equipped with a fluorescent detector, they gave extra peaks in the chromatograms ( Fig. lb and c) besides that of control FG (Fig. la) . These extra peaks probably correspond to adducts formed between the mutagens and FG, because they were not seen when control FG solution or mutagen solution alone waa analyzed by HPLC. This method was also applied to mutagens and carcinogens which require metabolic activation for their mutagenic action. "
The conditions used for preincubation of samples with S9 mix were exactly the same as those for the bacterial mutagenicity test, except that the bacterial cell suspension were replaced by FG solution (see experimental instead of FG as a starting reagent. As an example, we used IPG to characterize the mutagens in heated glucose. When glucose was heated at 200°C for 20 min, it became mutagenic to Salmonella strain TA100 without S9 mix (Fig. 2) , and its specific activity under optimum conditions was about 16^000 revertants/g. This specific activity is much weaker than that (6,000 because glucose heated at higher temperature contains many UV-absorbing materials that hinder the detection and isolation of IPG-adducts by HPLC.
The HPLC profile of the reaction mixture of heated glucose with IPG is shown in Fig. 3 . The chromatogram shows two peaks of IPG-adducts (adduct-1 and adduct-2) eluted before and after the large IPG peak, respectively. These two peaks were not seen with control IPG solution or heated glucose solution alone, confirming that they were those of reaction products between IPG and components in heated glucose. Adduct-1 was unambiguously identified as glyoxal-IPG adduct (structure^) from similarity of its UV spectrum and retention time on HPLC to those of authentic glyoxal-IPG adduct which was prepared from glyoxal and IPG according to Shapiro and Hachmann. This adduct was degraded gradually to IPG during its purification by repeated HPLC.
The UV spectra of adduct-2 were very characteristic (Fig. 4) A correlation between mutagenic or carcinogenic activities and reactivities with guanosine was first reported by Wislocki e_t al. They monitored the 14 electrophilic reactivity of ultimate carcinogens with C-guanosine by measuring loss of radioactivity. In our method, a low concentration of the fluorescent reagent FG was enough for detection of small amounts of mutagens; the minimum quantity of mutagen detectable was about 5-50 ng.
Another advantage of our method is that all procedures can be finished within 1 hr.
In our second method IPG is used for identifying mutagens present in crude extract, because its adduct can be easily extracted from aqueous reaction mixture with an organic solvent such as ethyl acetate. This extraction procedure selectively separated ire and IPG-adducts from most other components of heated glucose. Thus the heated glucose-IPG-adducts could be isolated very easily. Furthermore, it was easy to determine whether the extra peaks separated by HPLC were those of derivatives of IPG or components of heated glucose by measuring their UV spectra.
The detection of 8-hydroxy-IPG in the reaction mixture of IPG and heated glucose raises interesting questions. What component in heated glucose is responsible for the C-8 hydroxylation of IPG? What is the mechanism of the hydroxylation? How much is this reaction involved in mutagenesis? Recently, we observed that various reducing agents, such as ascorbic acid, hydroxylamine, hydrazine, sodium bisulfite, dihydroxymaleic acid and acetol, hydroxylate guanosine or deoxyguanosine at the C-8 position 14
in the presence of oxygen. Therefore, it is possible that various reducing agents produced by heating glucose, for example acetol and other reductones, might be responsible for the hydroxylation of IPG by heated glucose. It was also found that ascorbic acid hydroxylates guanine residues 14 in DNA.
Studies are now in progress to significance of this modification of DNA. 14 in DNA.
Studies are now in progress to elucidate the biological
